Sara Pepe | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab	ANNALS OF HEMATOLOGY	2021
Hemoglobin Changes during Long-Lasting Frontline Treatment with Tyrosine-Kinase Inhibitors in Patients with Chronic Myeloid Leukemia	BLOOD	2021
Digital droplet PCR as a predictive tool for successful discontinuation outcome in chronic myeloid leukemia: Is it time to introduce it in the clinical practice?	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2021
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients	ANNALS OF HEMATOLOGY	2021
Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of 2001 WHO Versus 2008/2016 WHO Criteria in a Large Single-center Cohort	CLINICAL LYMPHOMA MYELOMA & LEUKEMIA	2021
Predictive factors for response and survival in elderly acute myeloid leukemia patients treated with hypomethylating agents: a real-life experience	ANNALS OF HEMATOLOGY	2020
The advantages and risks of ruxolitinib for the treatment of polycythemia vera	EXPERT REVIEW OF HEMATOLOGY	2020
Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab	ANNALS OF HEMATOLOGY	2020
Switch from branded to generic imatinib: impact on molecular responses and safety in chronic-phase chronic myeloid leukemia patients	ANNALS OF HEMATOLOGY	2020
Digital droplet PCR as a predictive tool for successful discontinuation outcome in chronic myeloid leukemia: Is it time to introduce it in the clinical practice?	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2020
Predictive factors for response and survival in elderly acute myeloid leukemia patients treated with hypomethylating agents: a real-life experience	ANNALS OF HEMATOLOGY	2020
The advantages and risks of ruxolitinib for the treatment of polycythemia vera	EXPERT REVIEW OF HEMATOLOGY	2020
Switch from branded to generic imatinib: impact on molecular responses and safety in chronic-phase chronic myeloid leukemia patients	ANNALS OF HEMATOLOGY	2020
Oral mucositis prevention in allogeneic hematopoietic stem cell transplantation with the photobyomodulation: A single center case series	BONE MARROW TRANSPLANTATION	2019
ANTI-HLA DONOR SPECIFIC ANTIBODIES (DSA) IN THE TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS AND DESENSITIZATION STRATEGY. UNICENTRIC PERSPECTIVE STUDY	HAEMATOLOGICA	2019
Incidence and outcome of severe complications in patients with paroxysmal nocturnal hemoglobinuria: A real life scenario from a single center 30 years experience	BONE MARROW TRANSPLANTATION	2019
A 35 year single center transplant experience in chronic myeloid leukemia	BONE MARROW TRANSPLANTATION	2019
Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases	AMERICAN JOURNAL OF HEMATOLOGY	2018
Balancing efficacy and toxicity of targeted agents currently used for the treatment of patients with chronic lymphocytic leukemia	EXPERT REVIEW OF HEMATOLOGY	2018
Immune-hematologic monitoring after allogeneic stem cell transplantation: unicentric prospective study on 104 patients.	BONE MARROW TRANSPLANTATION	2018